ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,466, issued on April 29, was assigned to KAHR Medical Ltd. (Modiln Makabim-ReUt, Israel).
"PD1-4-1BBL variant fusion protein and methods of use thereof" was invented by Iris Pecker (Rishon LeZion, Israel) and Itai Bloch (Moshav Ramot Naftali, Israel).
According to the abstract* released by the U.S. Patent & Trademark Office: "PD1-4-1BBL variant fusion proteins are provided. Also provided are isolated polypeptides comprising a PD1 variant or a 4-1BBL variant. Also provided are polynucleotides and nucleic acid constructs encoding the PD1-4-1BBL fusion protein or the isolated polypeptide, host-cells expressing the same and methods of use thereof."
The patent was filed on July 11, 20...